Sara Bobillo-Perez, Javier Rodríguez-Fanjul, Iolanda Jordan Garcia
{"title":"降钙素原对儿科重症患者有用吗？","authors":"Sara Bobillo-Perez, Javier Rodríguez-Fanjul, Iolanda Jordan Garcia","doi":"10.1177/1177271918792244","DOIUrl":null,"url":null,"abstract":"<p><p>This review examines the use of procalcitonin in different clinical situations in the pediatric patient, with special emphasis on those requiring intensive care. We review the latest articles on its potency as a biomarker in both infectious processes at diagnosis and on the response to treatment.</p>","PeriodicalId":47060,"journal":{"name":"Biomarker Insights","volume":"13 ","pages":"1177271918792244"},"PeriodicalIF":3.4000,"publicationDate":"2018-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c0/be/10.1177_1177271918792244.PMC6081751.pdf","citationCount":"0","resultStr":"{\"title\":\"Is Procalcitonin Useful in Pediatric Critical Care Patients?\",\"authors\":\"Sara Bobillo-Perez, Javier Rodríguez-Fanjul, Iolanda Jordan Garcia\",\"doi\":\"10.1177/1177271918792244\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This review examines the use of procalcitonin in different clinical situations in the pediatric patient, with special emphasis on those requiring intensive care. We review the latest articles on its potency as a biomarker in both infectious processes at diagnosis and on the response to treatment.</p>\",\"PeriodicalId\":47060,\"journal\":{\"name\":\"Biomarker Insights\",\"volume\":\"13 \",\"pages\":\"1177271918792244\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2018-08-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c0/be/10.1177_1177271918792244.PMC6081751.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biomarker Insights\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/1177271918792244\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2018/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomarker Insights","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1177271918792244","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
Is Procalcitonin Useful in Pediatric Critical Care Patients?
This review examines the use of procalcitonin in different clinical situations in the pediatric patient, with special emphasis on those requiring intensive care. We review the latest articles on its potency as a biomarker in both infectious processes at diagnosis and on the response to treatment.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
